New platform outlines near-term execution plans and long-term AI growth strategy across consumer and healthcare markets.
Medical Care Technologies Inc. (USOTC:MDCE) announced a corporate website launch alongside expanded transparency initiatives, giving investors a clearer view of its AI-focused strategy, capital plans, and multi-phase growth roadmap.
Key Investor Takeaways
- Medical Care Technologies website launch provides increased visibility into its AI strategy and development timeline.
- The company is prioritizing near-term revenue generation through AI mobile apps and existing subsidiaries.
- Plans to expand into medical-grade AI applications could open new market opportunities but involve longer development cycles.
- Capital strategy includes both potential Regulation A funding and non-dilutive asset sales to support growth.
- A potential OTCQB uplisting is part of long-term positioning, which may impact investor perception and liquidity.
Press Release Overview
Medical Care Technologies launched a redesigned corporate website aimed at improving investor communication and transparency around its operations and strategy.
The platform outlines a structured roadmap divided into short-term, near-term, and long-term goals.
Short-Term Priorities
The company is focused on execution and capital efficiency, including:
- Liquidating up to $250,000 in subsidiary assets to fund AI development (approximately $200,000 already secured)
- Launching an upgraded version of its AI mobile app, Snapshot Recipes
- Developing additional AI applications across health, wellness, and dietary categories
- Continuing revenue generation from subsidiaries Infinite Auctions and Real Game Used
- Advancing testing of AI-based consumer and medical applications
Near-Term Goals (2026)
Key initiatives include:
- Development of medical-grade beta AI applications
- Structured beta testing, including collaboration with academic groups
- Expansion of AI platforms across consumer and healthcare use cases
- Marketing efforts through influencers and agencies
- Exploration of venture capital partnerships and acquisitions of AI technologies
Long-Term Objectives (2027 and Beyond)
The company outlined broader strategic goals such as:
- Pursuing clinical and institutional partnerships
- Evaluating regulatory pathways for medical AI
- Seeking an uplisting to the OTCQB
- Advancing patent-related AI image analysis technology
- Moving select applications toward clinical-grade validation
Capital Strategy
Medical Care Technologies indicated that a Regulation A offering could be used as a funding tool if share prices improve, while also emphasizing non-dilutive funding through asset sales.
CEO Commentary
CEO Marshall Perkins stated:
“We believe transparency, execution, and communication are critical as we continue to build. This updated platform gives investors a clear view of our roadmap. At the same time, we are committed to improving how we communicate with shareholders by providing more direct updates and addressing questions in real time on X. Whether it’s our last funding cycle or the rollout of Snapshot Recipes, we have learned valuable lessons that are helping us evolve as a company with a stronger future. Our focus remains on building long-term value as we execute across multiple high-growth AI verticals.”
Why This Matters for Investors
The corporate website launch and roadmap disclosure may signal an effort by Medical Care Technologies to improve transparency and investor engagement, which can be particularly relevant for smaller-cap companies.
The outlined strategy suggests a dual-track approach: generating near-term revenue through consumer AI applications while investing in longer-term opportunities in healthcare AI. This could broaden the company’s potential addressable market, though execution timelines and regulatory requirements may introduce uncertainty.
The capital strategy also highlights a balance between raising funds and limiting dilution, which may be a key consideration for investors evaluating future financing risk.
Overall, the update provides more clarity on direction, but the company remains in a development-heavy phase where execution and funding will likely be critical.
What to Watch For Next
- Launch and adoption of the updated Snapshot Recipes app
- Progress on medical-grade AI application development and testing
- Any partnerships with academic institutions or venture capital firms
- Execution of asset sales and potential Regulation A funding
- Developments related to a possible OTCQB uplisting
Conclusion
Medical Care Technologies (MDCE) is using its website launch to outline a clearer AI-driven growth strategy and improve communication with investors.
While the roadmap provides greater visibility into future plans, investors will likely focus on execution, funding strategy, and whether near-term initiatives can translate into measurable revenue growth.